Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook
1. IDEXX reported Q3 earnings of $3.22 per share, beating estimates. 2. Sales increased 13% to $1.105 billion, exceeding consensus expectations. 3. Companion Animal Group revenue grew 14%, indicating strong market demand. 4. Guidance for 2025 earnings increased to $12.81-$13.01 per share. 5. Analysts maintain positive outlook despite market concerns.